Another interesting data extracted from this study was that the phosphorylation of EPHA2 at its critical serine 897 contributes to the activation of the oncogenic non-canonical process in both osteosarcoma and chondrosarcoma patient-derived xenograft models. Here, EPHA2 is linked to chondrosarcoma.